PL202623B1
(pl)
|
2000-06-28 |
2009-07-31 |
Smithkline Beecham Plc |
Sposób wytwarzania drobno zmielonego preparatu substancji leczniczej, drobno zmielona substancja lecznicza wytworzona tym sposobem i zawierająca ją kompozycja farmaceutyczna
|
AU2002246864A1
(en)
|
2000-12-27 |
2002-07-24 |
The Trustees Of Columbia University In The City Of New York |
Pim kinase-related methods
|
KR100888093B1
(ko)
*
|
2001-03-30 |
2009-03-11 |
킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 |
약제학적 활성 화합물 및 이의 사용 방법
|
DE10123055A1
(de)
|
2001-05-11 |
2003-03-20 |
Gruenenthal Gmbh |
Screeningverfahren mit PIM1-Kinase oder PIM3-Kinase
|
DE10226702A1
(de)
|
2002-06-14 |
2004-09-09 |
Grünenthal GmbH |
Antisense Oligonukleotide gegen PIM1
|
WO2006078228A1
(en)
|
2002-09-16 |
2006-07-27 |
Plexxikon, Inc. |
Methods for the design of molecular scaffolds and ligands
|
EP1558751A4
(en)
|
2002-09-16 |
2007-08-22 |
Plexxikon Inc |
CRYSTALLINE STRUCTURE OF PROTEIN KINASE PIM-1
|
CL2003002287A1
(es)
|
2002-11-25 |
2005-01-14 |
Wyeth Corp |
COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
|
WO2004090106A2
(en)
|
2003-04-04 |
2004-10-21 |
Vertex Pharmaceuticals Incorporated |
Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
|
WO2005028624A2
(en)
|
2003-09-15 |
2005-03-31 |
Plexxikon, Inc. |
Molecular scaffolds for kinase ligand development
|
WO2005033310A1
(de)
|
2003-10-01 |
2005-04-14 |
Grünenthal GmbH |
Pim-1-spezifische dsrna-verbindungen
|
WO2006006569A1
(ja)
|
2004-07-12 |
2006-01-19 |
Nihon Nohyaku Co., Ltd. |
フェニルピリジン類又はその塩類、これらを有効成分とする除草剤及びその使用方法
|
KR101328273B1
(ko)
|
2004-12-28 |
2013-11-14 |
키넥스 파마슈티컬즈, 엘엘씨 |
세포 증식 질환의 치료를 위한 조성물 및 방법
|
RS52010B
(en)
|
2005-06-22 |
2012-04-30 |
Plexxikon Inc. |
DERIVATI PIROLO [2, 3-B] PIRIDINA KAO INHIBITORI PROTEIN KINAZE
|
WO2007011760A2
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
EP1749822B1
(en)
*
|
2005-08-05 |
2008-10-15 |
Hybrigenics S.A. |
Novel cysteine protease inhibitors and their therapeutic applications
|
AU2006302174B2
(en)
|
2005-10-06 |
2013-06-20 |
Exelixis, Inc. |
Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3
|
US7776865B2
(en)
|
2005-10-06 |
2010-08-17 |
Schering Corporation |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
WO2007048065A2
(en)
|
2005-10-21 |
2007-04-26 |
Exelixis, Inc. |
Pyrimidinones as casein kinase ii (ck2) modulators
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
WO2007084857A2
(en)
|
2006-01-13 |
2007-07-26 |
President And Fellows Of Harvard College |
Methods and compositions for treating cell proliferative disorders
|
WO2007131191A2
(en)
|
2006-05-05 |
2007-11-15 |
Perkinelmer Life And Analytical Sciences |
Mass spectrometry methods for multiplexed quantification of protein kinases and phosphatases
|
EP2041071B1
(en)
|
2006-06-29 |
2014-06-18 |
Kinex Pharmaceuticals, LLC |
Biaryl compositions and methods for modulating a kinase cascade
|
PT2041071E
(pt)
|
2006-06-29 |
2014-09-23 |
Kinex Pharmaceuticals Llc |
Composições de biarilo e processos para a regulação de uma cascata de cinases
|
ATE517868T1
(de)
|
2006-08-16 |
2011-08-15 |
Boehringer Ingelheim Int |
Pyrazinverbindungen, ihre verwendung und herstellungsverfahren
|
WO2008045252A2
(en)
|
2006-10-04 |
2008-04-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Engineered integrin binding peptides
|
US8318735B2
(en)
|
2006-10-31 |
2012-11-27 |
Merck Sharp & Dohme Corp. |
2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
|
JP5357763B2
(ja)
|
2006-11-06 |
2013-12-04 |
トレロ ファーマシューティカルズ, インコーポレイテッド |
イミダゾ[1,2−b]ピリダジン誘導体およびピラゾロ[1,5−a]ピリダジン誘導体およびプロテインキナーゼインヒビターとしてのこれらの使用
|
WO2008082839A2
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
WO2008082840A1
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
JP5330274B2
(ja)
|
2007-03-01 |
2013-10-30 |
ノバルティス アーゲー |
Pimキナーゼ阻害剤およびその使用方法
|
JP2010522765A
(ja)
|
2007-03-28 |
2010-07-08 |
アレイ バイオファーマ、インコーポレイテッド |
受容体チロシンキナーゼとしてのイミダゾ[1,2−a]ピリジン化合物
|
WO2008124323A1
(en)
|
2007-04-03 |
2008-10-16 |
Array Biopharma Inc. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
CN102317266A
(zh)
|
2007-04-25 |
2012-01-11 |
埃克塞利希斯股份有限公司 |
作为pim调节剂的6-苯基嘧啶酮类
|
KR20100017359A
(ko)
|
2007-04-25 |
2010-02-16 |
엑셀리시스, 인코포레이티드 |
카제인 키나제 ⅱ (ck2)조절제로서의 피리미디논
|
JP5241834B2
(ja)
|
2007-07-19 |
2013-07-17 |
メルク・シャープ・アンド・ドーム・コーポレーション |
プロテインキナーゼ阻害剤としての複素環アミド化合物
|
CN101808666A
(zh)
|
2007-07-31 |
2010-08-18 |
先灵公司 |
作为抗癌治疗的抗有丝分裂剂和激光激酶抑制剂组合
|
WO2009019274A1
(en)
*
|
2007-08-06 |
2009-02-12 |
Janssen Pharmaceutica Nv |
Substituted phenylenediamines as inhibitors of the interaction between mdm2 and p53
|
CA2743756A1
(en)
|
2007-11-15 |
2009-05-22 |
Musc Foundation For Research Development |
Inhibitors of pim protein kinases, compositions, and methods for treating cancer
|
CA2705862C
(en)
|
2007-11-16 |
2018-03-27 |
San Diego State University Research Foundation |
Compositions and method for manipulating pim-1 activity in circulatory system cells
|
EP2259678A4
(en)
|
2008-02-29 |
2011-07-27 |
Cylene Pharmaceuticals Inc |
PROTEIN KINASE MODULATORS
|
US8168794B2
(en)
|
2008-03-03 |
2012-05-01 |
Novartis Ag |
Pim kinase inhibitors and methods of their use
|
AR070531A1
(es)
|
2008-03-03 |
2010-04-14 |
Novartis Ag |
Inhibidores de cinasa pim y metodos para su uso
|
MX2010012103A
(es)
|
2008-05-12 |
2011-04-04 |
Amnestix Inc |
Compuestos para la inhibicion de la cinasa rho y para mejorar el aprendizaje y la memoria.
|
US8124649B2
(en)
|
2008-06-30 |
2012-02-28 |
Cylene Pharmaceuticals, Inc. |
Oxindole compounds
|
TWI461423B
(zh)
|
2008-07-02 |
2014-11-21 |
Astrazeneca Ab |
用於治療Pim激酶相關病狀及疾病之噻唑啶二酮化合物
|
FR2933409B1
(fr)
|
2008-07-03 |
2010-08-27 |
Centre Nat Rech Scient |
NOUVEAUX PYRROLO °2,3-a! CARBAZOLES ET LEUR UTILISATION COMME INHIBITEURS DES KINASES PIM
|
WO2010022081A1
(en)
|
2008-08-19 |
2010-02-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as pim kinase inhibitors
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為pim激酶抑制劑之三唑吡啶化合物
|
CA2735782A1
(en)
|
2008-09-02 |
2010-03-11 |
Novartis Ag |
Heterocyclic pim-kinase inhibitors
|
RS54506B1
(en)
|
2008-09-02 |
2016-06-30 |
Novartis Ag |
PICOLINAMIDE DERIVATIVES AS KINASE INHIBITORS
|
JP5564045B2
(ja)
|
2008-09-02 |
2014-07-30 |
ノバルティス アーゲー |
二環式キナーゼ阻害剤
|
TWI577680B
(zh)
|
2008-10-22 |
2017-04-11 |
亞雷生物製藥股份有限公司 |
作為TRK激酶抑制劑之經取代吡唑并〔1,5-a〕嘧啶化合物
|
GB0821307D0
(en)
|
2008-11-21 |
2008-12-31 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
AR074830A1
(es)
|
2008-12-19 |
2011-02-16 |
Cephalon Inc |
Pirrolotriazinas como inhibidores de alk y jak2
|
KR20130009577A
(ko)
*
|
2009-04-20 |
2013-01-23 |
오스펙스 파마슈티컬즈 엘엘씨 |
야누스 키나아제 3의 피페리딘 억제제
|
US20120128631A1
(en)
|
2009-05-19 |
2012-05-24 |
San Diego State University (SDSU) Foundation, dba San Diego State University (SDSU) Research |
Compositions and methods for kinase-mediated cytoprotection and enhanced cellular engraftment and persistence
|
MX2011012369A
(es)
|
2009-05-20 |
2012-03-16 |
Cylene Pharmaceuticals Inc |
Pirazolopirimidinas y heterociclos relacionados como inhibidores de cinasa.
|
US20100298302A1
(en)
|
2009-05-20 |
2010-11-25 |
Fabrice Pierre |
Novel protein kinase modulators
|
BRPI1012159B1
(pt)
|
2009-05-22 |
2022-01-25 |
Incyte Holdings Corporation |
Compostos derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d] pirimidinas e pirrol-3-il-pirrolo[2,3-d] pirimidinas como inibidores de janus cinase, composições farmacêuticas compreendendo os referidos compostos e usos dos mesmos
|
WO2010148351A1
(en)
|
2009-06-18 |
2010-12-23 |
Cylene Pharmaceuticals, Inc. |
Rhodanines and related heterocycles as kinase inhibitors
|
PL2448938T3
(pl)
|
2009-06-29 |
2014-11-28 |
Incyte Holdings Corp |
Pirymidynony jako inhibitory PI3K
|
BR112012004304A2
(pt)
|
2009-08-26 |
2016-03-15 |
Cylene Pharmaceuticals Inc |
quinolinas condensadas como moduladores de proteína cinase.
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
JP5567136B2
(ja)
|
2009-09-08 |
2014-08-06 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
4−置換ピリジン−3−イル−カルボキサミド化合物及び使用方法
|
US8435976B2
(en)
|
2009-09-08 |
2013-05-07 |
F. Hoffmann-La Roche |
4-substituted pyridin-3-yl-carboxamide compounds and methods of use
|
BR112012005550A2
(pt)
|
2009-09-11 |
2015-09-08 |
Cylene Pharmaceuticals Inc |
lactamas heterociclo-substituídas farmaceuticamente úteis
|
BR112012005957A2
(pt)
|
2009-09-16 |
2019-09-24 |
Cylene Pharmaceuticals Inc |
compostos tricíclicos e usos farmacêuticos dos mesmos
|
CA2774266A1
(en)
|
2009-09-16 |
2011-03-24 |
Cylene Pharmaceuticals, Inc. |
Novel tricyclic protein kinase modulators
|
KR101690358B1
(ko)
|
2009-10-29 |
2017-01-09 |
제노스코 |
키나아제 억제제
|
EP2332917B1
(en)
|
2009-11-11 |
2012-08-01 |
Sygnis Bioscience GmbH & Co. KG |
Compounds for PIM kinase inhibition and for treating malignancy
|
CA2780031A1
(en)
|
2009-11-12 |
2011-05-19 |
Selvita S.A. |
A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
|
MY160820A
(en)
|
2009-11-13 |
2017-03-31 |
Genosco |
Kinase inhibitors
|
WO2011063398A1
(en)
|
2009-11-23 |
2011-05-26 |
Cylene Pharamaceuticals, Inc. |
Polymorphs and salts of a kinase inhibitor
|
RU2607453C2
(ru)
|
2009-12-04 |
2017-01-10 |
Сенхва Байосайенсиз, Инк. |
Пиразолопиримидины и родственные гетероциклы как ск2 ингибиторы
|
WO2011075613A1
(en)
|
2009-12-18 |
2011-06-23 |
Sanofi |
Azaindole derivatives, their preparation and their therapeutic application
|
WO2011075630A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
JP5793505B2
(ja)
|
2009-12-23 |
2015-10-14 |
ジャスコ ファーマシューティカルズ, エルエルシー |
アミノピリミジンキナーゼ阻害薬
|
GB201002861D0
(en)
|
2010-02-19 |
2010-04-07 |
Cxr Biosciences Ltd |
Compositions
|
KR102283091B1
(ko)
|
2010-03-10 |
2021-07-30 |
인사이트 홀딩스 코포레이션 |
Jak1 저해제로서의 피페리딘4일 아제티딘 유도체
|
SG184475A1
(en)
|
2010-04-07 |
2012-11-29 |
Hoffmann La Roche |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
WO2011130342A1
(en)
|
2010-04-14 |
2011-10-20 |
Incyte Corporation |
FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS
|
US9062055B2
(en)
|
2010-06-21 |
2015-06-23 |
Incyte Corporation |
Fused pyrrole derivatives as PI3K inhibitors
|
JP2013530199A
(ja)
|
2010-07-06 |
2013-07-25 |
ノバルティス アーゲー |
キナーゼ阻害剤として有用な環状エーテル化合物
|
CN110003219A
(zh)
|
2010-07-13 |
2019-07-12 |
弗·哈夫曼-拉罗切有限公司 |
作为irak4调节剂的吡唑并[1,5a]嘧啶和噻吩并[3,2b]嘧啶衍生物
|
US8227773B2
(en)
|
2010-07-29 |
2012-07-24 |
Axcelis Technologies, Inc. |
Versatile beam glitch detection system
|
EA025611B1
(ru)
|
2010-07-29 |
2017-01-30 |
Райджел Фармасьютикалз, Инк. |
Активирующие ampk гетероциклические соединения и способы их использования
|
WO2012064981A2
(en)
|
2010-11-10 |
2012-05-18 |
National Jewish Health |
Methods to test allergic conditions
|
WO2012065297A1
(en)
|
2010-11-16 |
2012-05-24 |
Impact Therapeutics, Inc. |
3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
|
AR083933A1
(es)
|
2010-11-19 |
2013-04-10 |
Incyte Corp |
Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
|
JP5917544B2
(ja)
|
2010-11-19 |
2016-05-18 |
インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation |
Jak阻害剤としての複素環置換ピロロピリジンおよびピロロピリミジン
|
EP2649065A1
(en)
|
2010-12-09 |
2013-10-16 |
Amgen Inc. |
Bicyclic compounds as pim inhibitors
|
JP5980225B2
(ja)
|
2010-12-17 |
2016-08-31 |
ナーヴィアノ メディカル サイエンシズ エス.アール.エル. |
キナーゼ阻害剤としての置換ピラゾロ−キナゾリン誘導体
|
JP5961187B2
(ja)
|
2010-12-20 |
2016-08-02 |
インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation |
Pi3k阻害剤としてのn−(1−(置換フェニル)エチル)−9h−プリン−6−アミン
|
ES2602791T3
(es)
|
2011-01-26 |
2017-02-22 |
Nerviano Medical Sciences S.R.L. |
Derivados de pirrolo tricíclicos, proceso para su preparación y su uso como inhibidores de cinasa
|
WO2012101029A1
(en)
|
2011-01-26 |
2012-08-02 |
Nerviano Medical Sciences S.R.L. |
Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
|
ME02365B
(me)
|
2011-02-25 |
2016-06-20 |
Array Biopharma Inc |
Jedinjenja triazolopiridina kao inhibitori pim kinaze
|
US20120225061A1
(en)
|
2011-03-04 |
2012-09-06 |
Matthew Burger |
Tetrasubstituted cyclohexyl compounds as kinase inhibitors
|
UY33930A
(es)
|
2011-03-04 |
2012-10-31 |
Novartis Ag |
Inhibidores novedosos de quinasas
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
JP2014510105A
(ja)
|
2011-03-22 |
2014-04-24 |
アムジエン・インコーポレーテツド |
Pim阻害剤としてのアゾール化合物
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
KR20130133905A
(ko)
|
2011-04-05 |
2013-12-09 |
화이자 리미티드 |
트로포미오신-관련 키나제의 억제제인 피롤로[2,3-d]피리미딘 유도체
|
US9284298B2
(en)
|
2011-04-11 |
2016-03-15 |
Nerviano Medical Sciences S.R.L. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
CA2832865C
(en)
|
2011-04-22 |
2021-05-11 |
Jasco Pharmaceuticals, LLC |
Aminopyrimidine kinase inhibitors
|
GB201107176D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Pyrrolnitrin derivatives
|
GB201107197D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Compounds
|
EP2702063A1
(en)
|
2011-04-29 |
2014-03-05 |
Amgen Inc. |
Bicyclic pyridazine compounds as pim inhibitors
|
EP2710004A1
(en)
|
2011-05-17 |
2014-03-26 |
Bayer Intellectual Property GmbH |
Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
|
EP2710018B8
(en)
|
2011-05-19 |
2022-02-23 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Macrocyclic compounds as protein kinase inhibitors
|
KR20140048891A
(ko)
|
2011-05-27 |
2014-04-24 |
템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
치환된 2-벤질리덴-2H-벤조[b][1,4]티아진-3(4H)-온, 이의 유도체, 및 이의 치료적 용도
|
EP2714692B1
(en)
|
2011-06-01 |
2017-03-22 |
Bayer Intellectual Property GmbH |
Substituted aminoimidazopyridazines
|
WO2012170827A2
(en)
|
2011-06-08 |
2012-12-13 |
Cylene Pharmaceuticals, Inc. |
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
|
CN103797010B
(zh)
|
2011-06-20 |
2016-02-24 |
因塞特控股公司 |
作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
|
WO2012175591A1
(en)
|
2011-06-22 |
2012-12-27 |
Bayer Intellectual Property Gmbh |
Heterocyclyl aminoimidazopyridazines
|
ES2671748T3
(es)
|
2011-07-21 |
2018-06-08 |
Tolero Pharmaceuticals, Inc. |
Inhibidores heterocíclicos de proteína quinasas
|
CN102924445B
(zh)
|
2011-08-11 |
2015-07-08 |
上海吉铠医药科技有限公司 |
Pim激酶抑制剂及其制备方法与在制药中的应用
|
EP2742046A1
(en)
|
2011-08-12 |
2014-06-18 |
F.Hoffmann-La Roche Ag |
PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
HUE030869T2
(en)
*
|
2011-09-02 |
2017-06-28 |
Incyte Holdings Corp |
Heterocyclic amines as inhibitors of PI3K
|
JP5843524B2
(ja)
|
2011-09-02 |
2016-01-13 |
キヤノン株式会社 |
有機無機複合組成物、有機無機複合材料、光学素子および積層型回折光学素子
|
UA117092C2
(uk)
|
2011-09-06 |
2018-06-25 |
Байєр Інтеллектуал Проперті Гмбх |
Амінозаміщені імідазопіридазини
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
US8735528B1
(en)
*
|
2011-09-20 |
2014-05-27 |
The United States Of America As Represented By The Secretary Of The Air Force |
Two-photon absorbing cross-linked polyurethanes containing diphenylamino-dialkylfluorene-1,3,5-triazine units
|
CN103814029B
(zh)
|
2011-09-23 |
2016-10-12 |
拜耳知识产权有限责任公司 |
取代的咪唑并哒嗪
|
SG2014012579A
(en)
|
2011-09-27 |
2014-04-28 |
Hoffmann La Roche |
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
|
JP5998223B2
(ja)
|
2011-10-07 |
2016-09-28 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤としての置換3,4−ジヒドロピロロ[1,2−a]ピラジン−1(2H)−オン誘導体
|
JP6063945B2
(ja)
|
2011-10-07 |
2017-01-18 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤としての4−アルキル置換3,4−ジヒドロピロロ[1,2−a]ピラジン−1(2H)−オン誘導体
|
JP6215832B2
(ja)
|
2011-11-04 |
2017-10-18 |
ジャスコ ファーマスーティカルズ エルエルシーJasco Pharmaceuticals, LLC |
アミノピリミジンキナーゼ阻害剤
|
TW201348226A
(zh)
|
2012-02-28 |
2013-12-01 |
Amgen Inc |
作為pim抑制劑之醯胺
|
EP2822944A1
(en)
|
2012-03-05 |
2015-01-14 |
Amgen, Inc. |
Oxazolidinone compounds and derivatives thereof
|
EP2858993B1
(en)
|
2012-03-29 |
2018-01-10 |
Bayer Intellectual Property GmbH |
Amino-substituted imidazopyridazines
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
WO2013149909A1
(en)
|
2012-04-04 |
2013-10-10 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazopyridazines
|
US9688695B2
(en)
|
2012-04-26 |
2017-06-27 |
Bristol-Myers Squibb Company |
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
|
MA37439B1
(fr)
|
2012-04-27 |
2017-02-28 |
Novartis Ag |
Inhibiteurs de dgat1 à ponts éthers cycliques pour le traitement de troubles medies par l'acyle coa-diacylglycerol transferase 1 (dgat1).
|
GEP20237477B
(en)
|
2012-05-09 |
2023-03-27 |
Biogen Ma Inc Us |
Nuclear transport modulators and uses thereof
|
SI2861579T1
(en)
|
2012-05-15 |
2018-05-31 |
Novartis Ag |
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
|
US9193733B2
(en)
|
2012-05-18 |
2015-11-24 |
Incyte Holdings Corporation |
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
KR20150013548A
(ko)
|
2012-05-21 |
2015-02-05 |
노파르티스 아게 |
키나제 억제제로서의 신규 고리-치환된 n-피리디닐 아미드
|
SG11201407674TA
(en)
|
2012-05-22 |
2014-12-30 |
Idenix Pharmaceuticals Inc |
D-amino acid compounds for liver disease
|
TWI568722B
(zh)
|
2012-06-15 |
2017-02-01 |
葛蘭馬克製藥公司 |
作爲mPGES-1抑制劑之三唑酮化合物
|
JP6242885B2
(ja)
|
2012-06-27 |
2017-12-06 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
5−アザインダゾール化合物及び使用方法
|
AR092348A1
(es)
|
2012-07-11 |
2015-04-15 |
Hoffmann La Roche |
DERIVADOS DE ARIL-SULTAMO COMO MODULADORES DE RORc
|
TW201414737A
(zh)
|
2012-07-13 |
2014-04-16 |
必治妥美雅史谷比公司 |
作爲激酶抑制劑之咪唑并三□甲腈
|
WO2014022752A1
(en)
|
2012-08-03 |
2014-02-06 |
Amgen Inc. |
Macrocycles as pim inhibitors
|
WO2014033630A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
Novel aminothiazole carboxamides as kinase inhibitors
|
WO2014033631A1
(en)
|
2012-08-31 |
2014-03-06 |
Novartis Ag |
N-(3-pyridyl) biarylamides as kinase inhibitors
|
CN103664878A
(zh)
|
2012-09-12 |
2014-03-26 |
山东亨利医药科技有限责任公司 |
杂芳环及其衍生物类酪氨酸激酶抑制剂
|
UA116216C2
(uk)
|
2012-09-14 |
2018-02-26 |
Еббві Дойчланд Гмбх Унд Ко. Кг |
Трициклічні хінолінові і хіноксалінові похідні
|
CN104640858B
(zh)
|
2012-09-26 |
2018-11-06 |
霍夫曼-拉罗奇有限公司 |
环醚吡唑-4-基-杂环基-甲酰胺化合物及使用方法
|
WO2014053568A1
(en)
|
2012-10-02 |
2014-04-10 |
Sanofi |
Indolyldihydroimidazopyrimidinone derivatives, preparation thereof and therapeutic use thereof
|
LT2909195T
(lt)
|
2012-10-16 |
2017-09-25 |
Janssen Sciences Ireland Uc |
Antivirusiniai rsv junginiai
|
SG10201703533VA
(en)
|
2012-11-01 |
2017-06-29 |
Incyte Corp |
Tricyclic fused thiophene derivatives as jak inhibitors
|
ES2646916T3
(es)
|
2012-11-19 |
2017-12-18 |
Bayer Pharma Aktiengesellschaft |
Aminoimidazopiridazinas como inhibidores de MKNK1 cinasa
|
WO2014079011A1
(en)
|
2012-11-22 |
2014-05-30 |
Agios Pharmaceuticals, Inc. |
Heterocyclic compounds for inhibiting glutaminase and their methods of use
|
CA2892608C
(en)
|
2012-12-07 |
2021-10-19 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
ES2685975T3
(es)
|
2012-12-18 |
2018-10-15 |
Vertex Pharmaceuticals Incorporated |
Derivados de manosa para tratar las infecciones bacterianas
|
US20150336960A1
(en)
|
2012-12-19 |
2015-11-26 |
Novartis Ag |
Aryl-substituted fused bicyclic pyridazine compounds
|
WO2014097151A2
(en)
|
2012-12-19 |
2014-06-26 |
Novartis Ag |
Autotaxin inhibitors
|
MD4841B1
(ro)
|
2012-12-21 |
2023-01-31 |
Gilead Sciences, Inc. |
Compuşi policiclici de carbamoilpiridonă şi utilizarea lor farmaceutică
|
PT2935222T
(pt)
|
2012-12-21 |
2018-12-10 |
Epizyme Inc |
Inibidores de prmt5 e seus usos
|
FR3000569B1
(fr)
|
2013-01-03 |
2015-02-13 |
Peugeot Citroen Automobiles Sa |
Dispositif d'eclairage a ecran a bord(s) lumineux
|
JP6437452B2
(ja)
|
2013-01-14 |
2018-12-12 |
インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation |
Pimキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物
|
MX2015009057A
(es)
|
2013-01-15 |
2015-10-05 |
Incyte Corp |
Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de cinasa pim.
|
TWI736135B
(zh)
|
2013-03-01 |
2021-08-11 |
美商英塞特控股公司 |
吡唑并嘧啶衍生物治療PI3Kδ相關病症之用途
|
RS62867B1
(sr)
|
2013-03-06 |
2022-02-28 |
Incyte Holdings Corp |
Postupci i intermedijeri za dobijanje inhibitora jak
|
JO3383B1
(ar)
|
2013-03-14 |
2019-03-13 |
Lilly Co Eli |
مثبطات cdc7
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
AR095443A1
(es)
|
2013-03-15 |
2015-10-14 |
Fundación Centro Nac De Investig Oncológicas Carlos Iii |
Heterociclos condensados con acción sobre atr
|
EP2970282B1
(en)
|
2013-03-15 |
2019-08-21 |
Incyte Holdings Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
TWI689490B
(zh)
|
2013-03-15 |
2020-04-01 |
英商邊緣生物科技有限公司 |
用於治療纖維化之經取代之芳族化合物及相關方法
|
UY35421A
(es)
|
2013-03-15 |
2014-10-31 |
Nihon Nohyaku Co Ltd |
Compuesto heterocíclico condensado o su sal, insecticida agrícola u hortícola que comprende el comp uesto y método de uso del insecticida
|
JO3279B1
(ar)
|
2013-03-15 |
2018-09-16 |
Respivert Ltd |
مشتقات 2-((4- امينو -3- (3- فلورو-5- هيدروكسي فينيل)-h1- بيرازولو [d-3,4] بيرمدين-1-يل )ميثيل )- 3- (2- تراي فلورو ميثيل ) بينزيل ) كوينازولين -4 (h3)- واحد واستخدامها كمثبطات فوسفواينوسيتايد 3- كاينيز
|
RU2680100C9
(ru)
|
2013-03-15 |
2019-04-18 |
Плексксикон Инк. |
Гетероциклические соединения и их применения
|
PT2970236T
(pt)
|
2013-03-15 |
2017-11-30 |
Idorsia Pharmaceuticals Ltd |
Derivados de piridin-4-ilo
|
TWI689489B
(zh)
|
2013-03-15 |
2020-04-01 |
英商邊緣生物科技有限公司 |
用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
|
RS57188B1
(sr)
|
2013-03-15 |
2018-07-31 |
Japan Tobacco Inc |
Jedinjenje pirazol-amida i njegove medicinske upotrebe
|
WO2014139145A1
(en)
|
2013-03-15 |
2014-09-18 |
Hutchison Medipharma Limited |
Novel pyrimidine and pyridine compounds and usage thereof
|
CA2902711C
(en)
|
2013-03-15 |
2021-07-06 |
Global Blood Therapeutics, Inc. |
Substituted pyridinyl-6-methoxy-2-hydroxybenzaldehyde derivatives and pharmaceutical compositions thereof useful for the modulation of hemoglobin
|
ES2959637T3
(es)
|
2013-03-15 |
2024-02-27 |
Corteva Agriscience Llc |
4-Amino-6-(heterocíclico)picolinatos y 6-amino-2-(heterocíclico)pirimidin-4-carboxilatos y su uso como herbicidas
|
CN111454200A
(zh)
|
2013-03-15 |
2020-07-28 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
US20140275108A1
(en)
|
2013-03-15 |
2014-09-18 |
Galderma Research & Development |
Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
|
EP3030227B1
(en)
|
2013-08-07 |
2020-04-08 |
Incyte Corporation |
Sustained release dosage forms for a jak1 inhibitor
|
TW201605866A
(zh)
|
2013-08-23 |
2016-02-16 |
英塞特公司 |
可用作pim激酶抑制劑之呋喃并-及噻吩并-吡啶甲醯胺化合物
|
HUE041456T2
(hu)
|
2014-02-28 |
2019-05-28 |
Incyte Corp |
JAK1 inhibitorok myelodysplasiás szindrómák kezelésére
|
UA119767C2
(uk)
|
2014-04-08 |
2019-08-12 |
Інсайт Корпорейшн |
Лікування b-клітинних злоякісних новоутворень із застосуванням комбінації інгібіторів jak та pi3k
|
CA2947418A1
(en)
|
2014-04-30 |
2015-11-05 |
Incyte Corporation |
Processes of preparing a jak1 inhibitor and new forms thereto
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
WO2015191677A1
(en)
|
2014-06-11 |
2015-12-17 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
|
US9580418B2
(en)
|
2014-07-14 |
2017-02-28 |
Incyte Corporation |
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
|
US9822124B2
(en)
|
2014-07-14 |
2017-11-21 |
Incyte Corporation |
Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
|
US9540347B2
(en)
|
2015-05-29 |
2017-01-10 |
Incyte Corporation |
Pyridineamine compounds useful as Pim kinase inhibitors
|
AR105967A1
(es)
|
2015-09-09 |
2017-11-29 |
Incyte Corp |
Sales de un inhibidor de pim quinasa
|
WO2017059251A1
(en)
|
2015-10-02 |
2017-04-06 |
Incyte Corporation |
Heterocyclic compounds useful as pim kinase inhibitors
|